Email Stock Spams

[NLionGuy]

HPLF

SPECIAL SITUATION ALERT
To receive "Special Situation Alert" free, just send a blank email to: [e-mail]


HepaLife Technologies (OTC BB: HPLF)

Last sale: $1.74

"A $60 billion company, Medtronic (NYSE: MDT), created immense shareholder wealth by gambling on the Pacemaker 40 years ago. HepaLife Technologies could be next with the artificial liver."


HEPALIFE TECHNOLOGIES (OTC BB: HPLF) presents a true ground floor opportunity and the successful development of an artificial liver would be one of the greatest medical breakthroughs in recent memory. Similar to the pacemaker, heart valves, and kidney dialysis, HEPALIFE's artificial liver device aims to serve a huge and urgent medical need.

Serious liver donor shortages are creating two to three year delays - with some 30% of individuals not surviving this waiting period - and the problem continues to worsen. Major causes of liver disease (hepatitis, alcohol and drug abuse) are at epidemic proportions and are fuelling a medical crisis with NIH recently ranked liver disease among the top five leading causes of male death in America.

Just as the $60 billion company, Medtronic, changed the world with its pacemaker, so too could HPLF with its artificial liver. There are numerous examples of great wealth being created by the development of life saving medical technology. If you had acquired shares in a start-up company that initially developed dialysis technology or a company that developed the cancer drug, Taxol, you would have purchased shares in Baxter International (worth some $16 billion) and NYSE listed Bristol Myers Squibb.

To put HEPALIFE's potential into perspective, with virtually no direct competition, HPLF's revenues could top $1 billion with just a 1% market share. Based on the 56,613,332 shares issued and outstanding (as at July 24, 2003) that would represent sales of $17.66 per share which (on the same 7.22 price to sales ratio of MDT) would equate to a stock price of $127 per share.

HepaLife Technologies is worth serious attention. Visit its web site www.HepaLife.com and/or call 800-518-4879 and check out the unique characteristics of this company.


IMPORTANT NOTICE AND DISCLAIMER: The purpose of this advertisement, like any advertising, is to provide coverage and publicity for the advertised company, its products or services. The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country. Verify all claims and do your own due diligence. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. We recommend you use the information found in this advertisement as an initial starting point for conducting your own research on the advertised company in order to determine your own personal opinion of the company before investing. All information concerning the advertised company contained herein should be verified independently by an attorney, with such company and an independent licensed securities analyst. We are not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. Many states have established rules requiring the approval of a security by a state security administrator. Check with http://www.nasaa.org and call your state security administrator to determine whether a particular security is licensed for sale in your state. Many companies have information filed with state securities regulators and many will supply investors with additional information on request. All statements and opinions contained in this advertisement are the sole opinion of the authors and are subject to change without notice. We are not liable for any investment decisions by our readers. Readers should independently investigate and fully understand all risks before investing. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser or broker prior to completing any such purchase or sale decision. We are not registered investment advisers, or broker-dealers, or members of any financial regulatory bodies. The information contained in this advertisement is provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. We disclaim any and all liability as to the completeness or accuracy of the information and for any omissions of material facts. This advertisement may contain hyper links to web sites operated by third parties other than us. Such hyper links are provided for the reader's reference and convenience only. We are not responsible for the reliability of these external sites nor are we responsible for any of the contents, advertising, products, or other materials on such external sites. Our inclusion of hyper links to such web sites does not imply any endorsement of the material on such web sites or any association with their operators. Under no circumstances shall we be held responsible or liable, directly or indirectly, for any loss or damage caused or alleged to have been caused in connection with the use of or reliance on any content, goods, or services available on such external site. Any concerns regarding any external link should be directed to its respective site administrator or web master. We may refer to other sources of information, or other commentary. We intend to offer these items to readers as additional sources of information, but disclaim any implication that we endorse information contained in such outside sources. Any referral by us is no guarantee of the accuracy of any information provided by outside sources. As we disclaim any representation concerning source reliability, readers must contact information suppliers on their own and gauge to the reader's satisfaction the truthfulness of any source information. It should be understood that there is no guarantee past performance will be indicative of future results. Any reference to past performance(s) of companies previously advertised are specially selected to be referenced based on the favorable performance of these companies and the companies referenced may not be representative of all past advertised companies as not all past advertised companies may have performed as well. Readers are cautioned that small and micro-cap stocks are high-risk investments and that they may lose all or a portion of their investment if they make a purchase in our advertised stocks. In order to be in full compliance with the U.S. Securities Act of 1933, Section 17(b), we are receiving a total of U.S. $20,000 from National InfoSystems Inc. as compensation for the distribution of this and other advertisements. Since we are receiving compensation and hold stock in the advertised company there is an inherent conflict of interest in our statements and opinions and such statements and opinions cannot be considered independent. We will benefit from any increase in share price of the advertised company. We will sell our shares at any time, without notice, be that before, during or immediately after the release of this advertisement. The liquidation of our stock may have a negative impact on the securities of the company liquidated, including decreased market value and/or dilution of the company's securities. Furthermore, our associates and/or employees and/or principals may have stock positions in advertised companies purchased in the open market or in private transactions. These positions may be liquidated, without prior notification, even after we have made positive comments regarding the advertised company. It should be understood that any price targets and/or projections mentioned are solely opinions and should not be taken as suggested holding periods. In fact, we will sell our positions in any companies advertised before they reach such target prices. The receipt of this information constitutes your acceptance of these terms and conditions. Reading this advertisement shall not create under any circumstances an offer to buy or sell stock in any company advertised. Nor shall it create any principal-agent relationship between the reader and us. The stocks of advertised companies may trade in fast moving, highly volatile markets, and any reader should observe the trading behavior of any advertised company prior to investing. Advertised stocks are often thinly traded and large sell orders will have a substantially negative impact on share price. Investors in advertised stocks may experience difficulty in selling shares without seeing a decline in market price and may have difficulty in finding ready buyers of their stock. Information within this advertisement contains "forward looking" statements within the meaning of Section 27(a) of the U.S. Securities Act of 1933 and Section 21(e) of the U.S. Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be forward looking statements. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could or might occur. We encourage our readers to invest carefully and read the investor information available at the web sites of the U.S. Securities and Exchange Commission (SEC) at http://www.sec.gov and the National Association of Securities Dealers (NASD) at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. The NASD has published information on how to invest carefully at its web site. Readers can review all public filings by companies at the SEC s EDGAR page. All information within this advertisement is qualified in its entirety by the detailed information and financial statements of the advertised company contained in its regulatory filings with the SEC.